OVERSTOCK.COM INC (OSTK)

US6903701018 - Common Stock

16.78  +0.87 (+5.47%)

After market: 17 +0.22 (+1.31%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OSTK. OSTK was compared to 126 industry peers in the Specialty Retail industry. The financial health of OSTK is average, but there are quite some concerns on its profitability. OSTK has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

OSTK had negative earnings in the past year.
OSTK had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OSTK reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: OSTK reported negative operating cash flow in multiple years.

1.2 Ratios

OSTK has a Return On Assets of -16.97%. This is amonst the worse of the industry: OSTK underperforms 81.68% of its industry peers.
Looking at the Return On Equity, with a value of -24.00%, OSTK is doing worse than 64.12% of the companies in the same industry.
Industry RankSector Rank
ROA -16.97%
ROE -24%
ROIC N/A
ROA(3y)11.65%
ROA(5y)-7.67%
ROE(3y)18.42%
ROE(5y)-41.02%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

OSTK's Gross Margin of 22.84% is on the low side compared to the rest of the industry. OSTK is outperformed by 75.57% of its industry peers.
OSTK's Gross Margin has improved in the last couple of years.
OSTK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5Y3.32%

5

2. Health

2.1 Basic Checks

OSTK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OSTK has more shares outstanding
OSTK has more shares outstanding than it did 5 years ago.
OSTK has a worse debt/assets ratio than last year.

2.2 Solvency

OSTK has an Altman-Z score of 3.78. This indicates that OSTK is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.78, OSTK belongs to the best of the industry, outperforming 80.15% of the companies in the same industry.
OSTK has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
OSTK has a better Debt to Equity ratio (0.06) than 74.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 3.78
ROIC/WACCN/A
WACC9.19%

2.3 Liquidity

A Current Ratio of 1.97 indicates that OSTK should not have too much problems paying its short term obligations.
The Current ratio of OSTK (1.97) is better than 77.86% of its industry peers.
A Quick Ratio of 1.94 indicates that OSTK should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.94, OSTK belongs to the best of the industry, outperforming 87.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.94

1

3. Growth

3.1 Past

The earnings per share for OSTK have decreased strongly by -102.27% in the last year.
Looking at the last year, OSTK shows a very negative growth in Revenue. The Revenue has decreased by -42.51% in the last year.
OSTK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.03% yearly.
EPS 1Y (TTM)-102.27%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-110.53%
Revenue 1Y (TTM)-42.51%
Revenue growth 3Y10.37%
Revenue growth 5Y2.03%
Revenue growth Q2Q-60.32%

3.2 Future

Based on estimates for the next years, OSTK will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.97% on average per year.
Based on estimates for the next years, OSTK will show a decrease in Revenue. The Revenue will decrease by -0.93% on average per year.
EPS Next Y-352.74%
EPS Next 2Y-106.12%
EPS Next 3Y-22.55%
EPS Next 5Y12.97%
Revenue Next Year-19.05%
Revenue Next 2Y-6.61%
Revenue Next 3Y-2.73%
Revenue Next 5Y-0.93%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OSTK. In the last year negative earnings were reported.
Also next year OSTK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OSTK indicates a slightly more expensive valuation: OSTK is more expensive than 65.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 48.99

4.3 Compensation for Growth

OSTK's earnings are expected to decrease with -22.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-106.12%
EPS Next 3Y-22.55%

0

5. Dividend

5.1 Amount

OSTK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OVERSTOCK.COM INC

NASDAQ:OSTK (11/3/2023, 8:14:30 PM)

After market: 17 +0.22 (+1.31%)

16.78

+0.87 (+5.47%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap760.13M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.97%
ROE -24%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 22.84%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.06
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.97
Quick Ratio 1.94
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-102.27%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-352.74%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-42.51%
Revenue growth 3Y10.37%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y